2017
UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition.
Cell reports
•Cancer Specialist (Oncologist), Hematology and Oncology Specialist
239 publications
2017
Cell reports
•2016
Advances in cancer research
•2016
PLOS ONE
2015
Cell reports
•2015
Cell
•